Tatiana Novoselova

Tatiana Novoselova

Auto-generated profile, based on publicly available information

Tatiana Novoselova

Institute Health Sciences Education, Faculty of Medicine and Dentistry, Queen Mary University of London

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
TNT.V. Novoselova
T.V. Novoselova
LCLi Chan
Li Chan
ACA.J.L. Clark
A.J.L. Clark
The melanocortin receptors (MCRs) and their accessory proteins (MRAPs) are involved in regulation of a diverse range of endocrine pathways. Genetic variants of these components result in phenotypic variation and disease. The MC1R is expressed in skin and variants in the MC1R gene are associated with ginger hair color. The MC2R mediates the action of ACTH in the adrenal gland to stimulate glucocorticoid production and MC2R mutations result in familial glucocorticoid deficiency (FGD). MC3R and MC4R are involved in metabolic regulation and their gene variants are associated with severe pediatric obesity, whereas the function of MC5R remains to be fully elucidated. MRAPs have been shown to modulate the function of MCRs and genetic variants in MRAPs are associated with diseases including FGD type 2 and potentially early onset obesity. This review provides an insight into recent advances in MCRs and MRAPs physiology, focusing on the disorders associated with their dysfunction.

19 August 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
PSPaul E. Sladen
Paul E. Sladen
PPPedro Perdigão
Pedro Perdigão
GSGrace Salsbury
Grace Salsbury
TNTatiana Novoselova
Tatiana Novoselova
JSJacqueline van der Spuy
Jacqueline van der Spuy
MCMichael E. Cheetham
Michael E. Cheetham
Autosomal dominant optic atrophy (DOA) is the most common inherited optic neuropathy in the United Kingdom. DOA has an insidious onset in early childhood, typically presenting with bilateral, central visual loss caused by the preferential loss of retinal ganglion cells. 60%–70% of genetically confirmed DOA cases are associated with variants in OPA1, a ubiquitously expressed GTPase that regulates mitochondrial homeostasis through coordination of inner membrane fusion, maintenance of cristae structure, and regulation of bioenergetic output. Whether genetic correction of OPA1 pathogenic variants can alleviate disease-associated phenotypes remains unknown. Here, we demonstrate generation of patient-derived OPA1 c.1334G>A: p.R445H mutant induced pluripotent stem cells (iPSCs), followed by correction of OPA1 through CRISPR-Cas9-guided homology-directed repair (HDR) and evaluate the effect of OPA1 correction on mitochondrial homeostasis. CRISPR-Cas9 gene editing demonstrated an efficient method of OPA1 correction, with successful gene correction in 57% of isolated iPSCs. Correction of OPA1 restored mitochondrial homeostasis, re-establishing the mitochondrial network and basal respiration and ATP production levels. In addition, correction of OPA1 re-established the levels of wild-type (WT) mitochondrial DNA (mtDNA) and reduced susceptibility to apoptotic stimuli. These data demonstrate that nuclear gene correction can restore mitochondrial homeostasis and improve mtDNA integrity in DOA patient-derived cells carrying an OPA1 variant.

8 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
TNTatiana V Novoselova
Tatiana V Novoselova
NMNyree Myatt
Nyree Myatt
EMEsther Murray
Esther Murray
MMMaryam Malekigorji
Maryam Malekigorji
LRLesley G Robson
Lesley G Robson
Objective The use of smart drugs, including modafinil, in high-pressure situations has gathered increasing attention. However, there is a lack of studies exploring their use among medical students. To investigate awareness, usage, and opinions regarding modafinil among medical students to inform student support services. Design Approximately two thousand medical students (Years 1-5) were invited to participate in an anonymous survey comprising two sections: awareness/use of modafinil and opinions on its usage. The survey collected no demographic data and ensured participants’ anonymity. Methods Online 7-minute survey using MicrosoftForms with data collection for 14 weeks. Results The survey had a low response rate. Most respondents were familiar with smart drugs, learning about them from their friends and the media. Many participants (44%) reported using modafinil to enhance attention, focus, productivity, and exam performance. Users generally found the drug effective, with some noting long-lasting effects. However, some users experienced negative effects. Analysis of opinions revealed that respondents mostly did not consider modafinil as cheating and did not feel pressured to use it if others were. Conclusion The report provides a preliminary insight into the awareness and use of modafinil in medical students The survey’s low response rate highlights the challenges of investigating drug use related topics through surveys, suggesting other methods should be employed. Nonetheless, the study underscores the need for comprehensive, professionally curated advice and policies aimed at students support to mitigate the risks.

14 October 2014 in Endocrine Abstracts
Verified
Journal Article
Open access
LCLi Chan
Li Chan
TNTatiana Novoselova
Tatiana Novoselova
SRShoshana Rath
Shoshana Rath
KCKaren Carpenter
Karen Carpenter
NPNick Pachter
Nick Pachter
LMLou Metherell
Lou Metherell
Aberrant pseudoexon inclusion is rarely recognised as a cause of human disease. Here we report two novel, compound heterozygous mutations in nicotinamide nucleotide transhydrogenase (NNT), one of which activates a pseudoexon, as the cause of familial glucocorticoid deficiency in two siblings. Whole-exome sequencing identified a single novel, heterozygous variant (R71X) in both affected individuals. Follow-up cDNA analysis identified the pseudoexon inclusion (p.P998_D999ins23) and Sanger sequencing of genomic DNA identified a 4 bp duplication responsible for its’ activation. The variants segregated with the disease, R71X was inherited from the mother, P998_D999ins23 from the father and an unaffected sibling had inherited only the R71X variant. Neither variant has been annotated in any SNP or mutation databases and both will lead to premature truncation and presumably an inactive protein. The mutation resulting in pseudoexon inclusion could provide a potential target for antisense oligonucleotide therapy. Detection of such events in disease is hampered since introns, because of their frequently large size, are often excluded from mutational analyses, and it is often impossible/impractical to perform cDNA analysis.

14 October 2014 in Endocrine Abstracts
Verified
Journal Article
Closed access
TNTatiana Novoselova
Tatiana Novoselova
RLRachel Larder
Rachel Larder
DRDebra Rimmington
Debra Rimmington
CLChris Lelliott
Chris Lelliott
EWElizabeth Wynn
Elizabeth Wynn
LCLi Chan
Li Chan
Recently, rare loss-of-function mutations of melanocortin-2-receptor accessory protein 2 (MRAP2) have been associated with severe, early-onset obesity in humans. In addition, whole body deletion and targeted brain specific deletion of the Mrap2 gene resulted in severe obesity in mice. In vitro data have shown Mrap2 interaction with the melanocortin-4-receptor (MC4R) affecting receptor signalling as a consequence. However, the mechanism by which Mrap2 regulates body weight in vivo is less well understood with differences between Mrap2 and Mc4r knockout (KO) mice phenotypes. In this study we show that Mrap2 complete KO mice, derived from an independent line and on two separate genetic backgrounds, have severe early obesity without detectable changes to food intake or energy expenditure. Hence, replicating recently published data. To further investigate the in vivo role of Mrap2 as a Mc4r accessory protein we used a plasma membrane enrichment technique to demonstrate a reduction of hypothalamic Mc4r protein surface expression in Mrap2 KO mice compared with WT littermates. Taken together, this work corroborates the role of Mrap2 in obesity and confirms that, at least in part, this is due to defective central melanocortin trafficking.